Myopathy in glycogen storage disease type IV: case report of a family
https://doi.org/10.20538/1682-0363-2024-3-172-177
Abstract
Aim. To study the clinical presentation and differential diagnosis of a rare hereditary disease glycogen storage disease type IV with progressive skeletal myopathy in a case report of a family.
Materials and methods. Two patients were followed up in the specialized neurology unit of the regional clinical hospital and in the outpatient setting.
Results. Long-term follow-up and examination in two clinically similar cases of myopathy in siblings allowed us to diagnose a hereditary metabolic disease. The congenital muscular form of glycogen storage disease type IV was manifested by myopathy and peripheral tetraparesis with the development of bone deformities. Difficulty in the diagnosis was due to isolated myopathy progression with no signs of liver involvement. The diagnosis was established with account of clinical manifestations, the progressive course of the disease, electromyography findings, and the results of molecular genetic testing for pathogenic mutations associated with hereditary neuromuscular diseases.
Conclusion. Glycogen storage disease type IV can clinically manifest itself by progressive myopathy without liver involvement and changes in blood biochemistry. The presented clinical cases in siblings are identical. Myopathy does not have clinical features that are significant for the differential diagnosis with other hereditary neuromuscular diseases. Genetic testing identified a mutation in the GBE1 gene and is considered as the main diagnostic criterion of the disease.
About the Authors
I. F. FedoseevaRussian Federation
22a, Voroshilova Str., Kemerovo, 650056
T. V. Poponnikova
Russian Federation
22a, Voroshilova Str., Kemerovo, 650056
O. S. Pinevich
Russian Federation
22, Oktyabrsky Av., Kemerovo, 650061
References
1. Баранов А.А., Намазова-Баранова Л.С., Сурков А.Н., Гундобина О.С., Вишнева Е.А., Маргиева Т.В. и др. Ведение детей с гликогеновой болезнью (нозологические формы с поражением печени). Современные клинические рекомендации. Педиатрическая фармакология. 2020;17(4):303– 317. DOI: 10.15690/pf.v17i4.2159.
2. Gümüş E, Özen H. Glycogen storage diseases: an update. World J. Gastroenterol. 2023;29(25):3932–3963. DOI: 10.3748/wjg.v29.i25.3932.
3. Куцев С.И. Путь пациента с редким диагнозом: нормативные документы и организация лечебно-диагностического процесса при орфанном заболевании в Российской Федерации. Нервно-мышечные болезни. 2017;7(4):61–63. DOI: 10.17650/2222-8721-2017-7-4-61-63.
4. Попонникова Т.В., Федосеева И.Ф., Галиева Г.Ю., Мошнегуц С.В. Клинический случай редкого нейродегенеративного заболевания с накоплением железа в мозге, тип 4, у ребенка 15 лет. Российский вестник перинатологии и педиатрии. 2019;64(5):109–113. DOI: 10.21508/10274065-2019-64-5-109-113.
5. Федосеева И.Ф., Попонникова Т.В., Галиева Г.Ю., Илясова О.В. Клинические наблюдения поздней младенческой и юношеской форм болезни Ниманна – Пика, тип С. Бюллетень сибирской медицины. 2017;16(3):210–217. DOI: 10.20538/1682-0363-2017-3-210-217.
6. Moses S.W., Parvari R. The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies. Curr. Mol. Med. 2002;2(2):177–188. DOI: 10.2174/1566524024605815.
7. Ellingwood S.S., Cheng A. Biochemical and clinical aspects of glycogen storage diseases. J. Endocrinol. 2018;238(3):131– R141. DOI: 10.1530/JOE-18-0120.
Review
For citations:
Fedoseeva I.F., Poponnikova T.V., Pinevich O.S. Myopathy in glycogen storage disease type IV: case report of a family. Bulletin of Siberian Medicine. 2024;23(3):172-177. https://doi.org/10.20538/1682-0363-2024-3-172-177